Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Welte

Showing results (31-40 of 237) with videos related to

Pageof 24
Sort By:
Klinische Padiatrie|January 1, 1977
[The west-berlin therapy study of acute lymphoblastic leukemia in childhood--report after 6 years (author's transl)]H Riehm, H Gadner, K Welte
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|January 1, 1972
[Adaptation to a remedy demonstrated in chronic folic acid load (author's transl)]G E Schubert, G Otten, K Welte
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1988
The response of human marrow colony-forming units-granulocyte and macrophage to inhibition by prostaglandin E and acidic isoferritins is associated with expression of MHC class II antigens and requires the participation of a CD8+ T lymphokineL M Pelus, E Levi, K Welte
Annals of the New York Academy of Sciences|June 12, 2003
Thrombopoietin is essential for the maintenance of normal hematopoiesis in humans: development of aplastic anemia in patients with congenital amegakaryocytic thrombocytopeniaM Ballmaier, M Germeshausen, S Krukemeier, et al.
Blood|February 7, 1998
Diagnosis and clinical course of autoimmune neutropenia in infancy: analysis of 240 casesJ Bux, G Behrens, G Jaeger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1985
Prostaglandin E2 acts at two distinct pathways of T lymphocyte activation: inhibition of interleukin 2 production and down-regulation of transferrin receptor expressionS Chouaib, K Welte, R Mertelsmann, et al.
Haematology and Blood Transfusion|January 1, 1987
Cytokines with possible clinical utilityR Mertelsmann, J Kolitz, K Welte, et al.
Stem Cells (Dayton, Ohio)|January 1, 1997
Frequency of point mutations in the gene for the G-CSF receptor in patients with chronic neutropenia undergoing G-CSF therapyN Tidow, C Pilz, B Kasper, et al.
Experimental Hematology|March 18, 2000
Thrombopoietin induces the generation of distinct Stat1, Stat3, Stat5a and Stat5b homo- and heterodimeric complexes with different kinetics in human plateletsH Schulze, M Ballmaier, K Welte, et al.
Biochemical and Biophysical Research Communications|September 16, 1999
Thrombopoietin acts synergistically on Ca(2+) mobilization in platelets caused by ADP or thrombin receptor agonist peptideM Eilers, H Schulze, K Welte, et al.
Pageof 24

Showing results (31-40 of 237) with videos related to

Sort By:
Pageof 24
Klinische Padiatrie|January 1, 1977
[The west-berlin therapy study of acute lymphoblastic leukemia in childhood--report after 6 years (author's transl)]H Riehm, H Gadner, K Welte
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|January 1, 1972
[Adaptation to a remedy demonstrated in chronic folic acid load (author's transl)]G E Schubert, G Otten, K Welte
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1988
The response of human marrow colony-forming units-granulocyte and macrophage to inhibition by prostaglandin E and acidic isoferritins is associated with expression of MHC class II antigens and requires the participation of a CD8+ T lymphokineL M Pelus, E Levi, K Welte
Annals of the New York Academy of Sciences|June 12, 2003
Thrombopoietin is essential for the maintenance of normal hematopoiesis in humans: development of aplastic anemia in patients with congenital amegakaryocytic thrombocytopeniaM Ballmaier, M Germeshausen, S Krukemeier, et al.
Blood|February 7, 1998
Diagnosis and clinical course of autoimmune neutropenia in infancy: analysis of 240 casesJ Bux, G Behrens, G Jaeger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1985
Prostaglandin E2 acts at two distinct pathways of T lymphocyte activation: inhibition of interleukin 2 production and down-regulation of transferrin receptor expressionS Chouaib, K Welte, R Mertelsmann, et al.
Haematology and Blood Transfusion|January 1, 1987
Cytokines with possible clinical utilityR Mertelsmann, J Kolitz, K Welte, et al.
Stem Cells (Dayton, Ohio)|January 1, 1997
Frequency of point mutations in the gene for the G-CSF receptor in patients with chronic neutropenia undergoing G-CSF therapyN Tidow, C Pilz, B Kasper, et al.
Experimental Hematology|March 18, 2000
Thrombopoietin induces the generation of distinct Stat1, Stat3, Stat5a and Stat5b homo- and heterodimeric complexes with different kinetics in human plateletsH Schulze, M Ballmaier, K Welte, et al.
Biochemical and Biophysical Research Communications|September 16, 1999
Thrombopoietin acts synergistically on Ca(2+) mobilization in platelets caused by ADP or thrombin receptor agonist peptideM Eilers, H Schulze, K Welte, et al.
Pageof 24